TipRanks
Argenx Se (MX:ARGXN)
:ARGXN
Mexico Market
ARGXN
Argenx Se
RESEARCH TOOLSreports

Argenx Se (ARGXN) Stock Forecast & Price Target

1 Followers
See the Price Targets and Ratings of:

ARGXN Analyst Ratings

Strong Buy
21Ratings
Strong Buy
20 Buy
1 Hold
0 Sell
Based on 21 analysts giving stock ratings to
Argenx
Se
in the past 3 months
TipRanks enables you to focus on the analyst rating consensus of all analysts or only the top performers​ in the past 3 months

ARGXN Stock 12 Month Forecast

Average Price Target

$20,043.65
▲(34.59% Upside)
Based on 21 Wall Street analysts offering 12 month price targets for Argenx Se in the last 3 months. The average price target is $20,043.65 with a high forecast of $24,030.30 and a low forecast of $15,827.73. The average price target represents a 34.59% change from the last price of $14,892.29.
{"navigator":{"disabled":true},"exporting":{"enabled":false},"title":{"text":null},"chart":{"height":200,"style":{"fontFamily":"Roboto Flex, -apple-system, BlinkMacSystemFont, Segoe UI, Roboto, Helvetica, Arial, sans-serif, Apple Color Emoji, Segoe UI Emoji, Segoe UI Symbol","fontWeight":"400","color":"#5d5d5e"},"spacingTop":30,"spacingRight":60,"events":null},"yAxis":{"labels":{"style":{"color":"inherit"},"distance":6,"x":-6,"y":-6,"zIndex":1,"map_label_formatter":{"11384":"$11,384","24031":"$24,031","14545.75":"$14,545.8","17707.5":"$17,707.5","20869.25":"$20,869.3"}},"plotLines":[{"color":"rgba(0,0,0,0)","value":24030.29685925,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":-10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-bottom flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#199ca5\">High </span>\n\n  <span style=\"color:#199ca5\">$24K</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":20043.645136487503,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":0,"text":"<div  class=\"positionrelative hoverZ3 triangleleft flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#828080\">Average </span>\n\n  <span style=\"color:#828080\">$20K</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":15827.7290974,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-top flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#912767\">Low </span>\n\n  <span style=\"color:#912767\">$16K</span>\n  </div></div>","useHTML":true}}],"tickPositions":[11384,14545.75,17707.5,20869.25,24031],"lineColor":"#dddddd","gridLineWidth":1,"gridLineColor":"#dddddd","lineWidth":1,"title":{"text":""}},"plotOptions":{"series":{"states":{"inactive":{"opacity":1}}},"line":{"animation":{"duration":0},"dataLabels":{"allowOverlap":true},"borderWidth":1,"marker":{"enabled":true,"fillColor":"#FFFFFF","radius":3,"lineWidth":2,"symbol":"circle","lineColor":"#828080"}}},"xAxis":{"labels":{"style":{"color":"inherit"},"rotation":0,"map_label_formatter":{"3":"Dec<br/>2025","6":"Mar<br/>2026","9":"Jun<br/>2026","12":"Sep<br/>2026","25":"Sep<br/>2027"}},"tickPositions":[3,6,9,12,25],"plotLines":[{"color":"#dddddd","width":1,"value":12},{"color":"#dddddd","width":1,"value":12}],"lineWidth":0,"gridLineWidth":1,"gridLineColor":"#dddddd","tickLength":0},"legend":{"symbolRadius":0,"symbolPadding":4,"symbolHeight":14,"borderWidth":0,"symbolWidth":14,"align":"left","verticalAlign":"bottom","enabled":false},"tooltip":{"backgroundColor":"rgba(0,0,0,0)","useHTML":true,"borderWidth":0,"borderColor":"rgba(0,0,0,0)","padding":0,"shadow":null,"headerFormat":"","footerFormat":"","pointFormat":"<div class=\"flexccc lineHeight2 bgwhite shadow2 px3 py3 radiismall fonth10_semibold\">\n                <span class=\"colorgray-3 mb4\">{point.date:%b %d ,%Y}</span>\n                <span>Analyst Consensus</span>\n                {point.info}\n          </div>\n           </div>"},"credits":{"enabled":false},"accessibility":{"description":""},"responsive":{"rules":[{"chartOptions":{"chart":{"spacing":[0,0,0,0],"margin":[30,60,40,5]},"xAxis":{"tickPositions":[3,12,25.25]},"yAxis":{"labels":{"enabled":false}},"title":{"text":null},"subtitle":{"text":null}},"condition":{"maxWidth":500}}]},"series":[{"lineWidth":2,"dashStyle":"ShortDash","name":"High","type":"line","color":"#199ca5","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,14892.29,15595.213604557694,16298.137209115386,17001.060813673077,17703.98441823077,18406.908022788462,19109.831627346153,19812.755231903844,20515.67883646154,21218.602441019233,21921.526045576924,22624.449650134615,23327.373254692306,{"y":24030.29685925,"marker":{"fillColor":"#199ca5","lineColor":"#199ca5","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Average","type":"line","color":"#828080","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,14892.29,15288.548087422116,15684.806174844232,16081.064262266347,16477.322349688464,16873.580437110577,17269.838524532694,17666.09661195481,18062.354699376927,18458.61278679904,18854.870874221157,19251.12896164327,19647.387049065386,{"y":20043.645136487503,"marker":{"fillColor":"#828080","lineColor":"#828080","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Low","type":"line","color":"#912767","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,14892.29,14964.246853646155,15036.203707292309,15108.160560938462,15180.117414584616,15252.07426823077,15324.031121876924,15395.987975523078,15467.944829169232,15539.901682815385,15611.85853646154,15683.815390107693,15755.772243753847,{"y":15827.7290974,"marker":{"fillColor":"#912767","lineColor":"#912767","enabled":true,"symbol":"circle"}}]},{"type":"line","data":[{"y":11385,"date":1756684800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 48,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 2, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":14210,"date":1759276800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 52,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 2, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":15022,"date":1761955200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 36,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 2, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":15022,"date":1764547200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 37,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 4, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":15021.209,"date":1767225600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 39,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 5, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":15021.209,"date":1769904000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 49,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 5, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":13277.139,"date":1772323200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 39,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 3, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":13000.67,"date":1775001600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 29,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 3, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":13000.67,"date":1777593600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 38,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 3, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":13000.67,"date":1780272000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 56,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 2, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":15953.15,"date":1782864000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 76,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 2, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":15953.15,"date":1785542400000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 68,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 2, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":14892.29,"date":1788220800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 49,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 2, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"fillColor":"black","lineColor":"black","enabled":true,"symbol":"circle"}},null,null,null,null,null,null,null,null,null,null,null,null],"color":"#0666a7"}]}
Highest Price Target$24,030Average Price Target$20,044Lowest Price Target$15,828
The highest, average, and lowest price target of all analysts. Click on ‘Top Analysts’ to focus on the best performers.

Detailed List of Analyst Forecasts​

Detailed List of Analyst Forecasts​
Analyst Profile
Expert Firm
Price Target
Position
Upside / Downside
Action
Date
Follow
Article
Jefferies Analyst forecast on MX:ARGXN
Unknown Analyst
Jefferies
Not Ranked
Jefferies
$17,203.31→$20,633.79
Buy
38.55%
Upside
Reiterated
09/03/26
Argenx Se (ARGX) Gets a Buy from Jefferies
Wedbush Analyst forecast on MX:ARGXN
David Nierengarten
Wedbush
Wedbush
$19,529.92
Buy
31.14%
Upside
Reiterated
09/03/26
Analysts' Top Healthcare Picks: Argenx Se (ARGX), TELA Bio (TELA)
William Blair Analyst forecast on MX:ARGXN
Matt Phipps
William Blair
William Blair
―
Buy
―
Reiterated
09/02/26
Analysts Offer Insights on Healthcare Companies: Argenx Se (NASDAQ: ARGX) and Definitive Healthcare Corp (NASDAQ: DH)
Morgan Stanley Analyst forecast on MX:ARGXN
Sean Laaman
Morgan Stanley
Morgan Stanley
$21,228.18
Buy
42.54%
Upside
Assigned
09/01/26
Analysts Are Bullish on Top Healthcare Stocks: Argenx Se (ARGX), Ascendis Pharma (ASND)
Wells Fargo Analyst forecast on MX:ARGXN
Derek Archila
Wells Fargo
Wells Fargo
$22,926.43→$24,030.3
Buy
61.36%
Upside
Assigned
08/26/26
Analysts Offer Insights on Healthcare Companies: Solventum Corporation (NYSE: SOLV), Argenx Se (NASDAQ: ARGX) and Spyre Therapeutics (NASDAQ: SYRE)
UBS Analyst forecast on MX:ARGXN
Xian Deng
UBS
UBS
$16,303.24→$23,775.56
Buy
59.65%
Upside
Upgraded
08/26/26
UBS upgrades Argenx Se (ARGX) to a Buy
H.C. Wainwright Analyst forecast on MX:ARGXN
Douglas Tsao
H.C. Wainwright
H.C. Wainwright
$20,413.02
Buy
37.07%
Upside
Reiterated
08/24/26
Analysts Are Bullish on Top Healthcare Stocks: Enliven Therapeutics (ELVN), Argenx Se (ARGX)
Citizens JMP Analyst forecast on MX:ARGXN
Jason Butler
Citizens JMP
Citizens JMP
$15,827.73→$20,379.05
Buy
36.84%
Upside
Reiterated
08/18/26
Argenx price target raised to $1,200 from $932 at CitizensArgenx price target raised to $1,200 from $932 at Citizens
Truist Financial Analyst forecast on MX:ARGXN
Danielle Brill
Truist Financial
Truist Financial
$17,492.02→$18,595.88
Buy
24.87%
Upside
Reiterated
08/18/26
Argenx price target raised to $1,095 from $1,030 at TruistArgenx price target raised to $1,095 from $1,030 at Truist
Oppenheimer Analyst forecast on MX:ARGXN
Leland Gershell
Oppenheimer
Oppenheimer
$17,610.9→$18,680.8
Buy
25.44%
Upside
Reiterated
08/18/26
Argenx price target raised to $1,100 from $1,037 at OppenheimerArgenx price target raised to $1,100 from $1,037 at Oppenheimer
Citi Analyst forecast on MX:ARGXN
Samantha Semenkow
Citi
Citi
$20,430→$22,094.29
Buy
48.36%
Upside
Reiterated
08/18/26
Argenx Se (ARGX) Receives a Buy from Citi
TD Cowen Analyst forecast on MX:ARGXN
Yaron Werber
TD Cowen
TD Cowen
$19,461.99→$22,977.38
Buy
54.29%
Upside
Reiterated
08/17/26
Analysts Offer Insights on Healthcare Companies: Argenx Se (NASDAQ: ARGX) and Amgen (NASDAQ: AMGN)
Piper Sandler Analyst forecast on MX:ARGXN
Allison Bratzel
Piper Sandler
Piper Sandler
$18,256.23→$20,633.79
Buy
38.55%
Upside
Reiterated
08/17/26
Argenx price target raised to $1,215 from $1,075 at Piper SandlerArgenx price target raised to $1,215 from $1,075 at Piper Sandler
Bank of America Securities Analyst forecast on MX:ARGXN
Tazeen Ahmad
Bank of America Securities
Bank of America Securities
$18,477.01→$19,292.17
Buy
29.54%
Upside
Reiterated
08/17/26
Argenx price target raised to $1,136 from $1,088 at BofAArgenx price target raised to $1,136 from $1,088 at BofA
RBC Capital Analyst forecast on MX:ARGXN
Luca Issi
RBC Capital
RBC Capital
$17,407.11→$18,680.8
Buy
25.44%
Upside
Reiterated
08/17/26
Analysts Are Bullish on These Healthcare Stocks: Argenx Se (ARGX), Tenon Medical, Inc. (TNON)
Analyst Type
Any
Any
Human Analysts
Ranks
Any
Any
Analyst Rating
Any
Any
Upside/ Downside
Any
Any
Action
Any
Any
Analyst Profile
Expert Firm
Price Target
Position
Upside / Downside
Action
Date
Follow
Article
Jefferies Analyst forecast on MX:ARGXN
Unknown Analyst
Jefferies
Not Ranked
Jefferies
$17,203.31→$20,633.79
Buy
38.55%
Upside
Reiterated
09/03/26
Argenx Se (ARGX) Gets a Buy from Jefferies
Wedbush Analyst forecast on MX:ARGXN
David Nierengarten
Wedbush
Wedbush
$19,529.92
Buy
31.14%
Upside
Reiterated
09/03/26
Analysts' Top Healthcare Picks: Argenx Se (ARGX), TELA Bio (TELA)
William Blair Analyst forecast on MX:ARGXN
Matt Phipps
William Blair
William Blair
―
Buy
―
Reiterated
09/02/26
Analysts Offer Insights on Healthcare Companies: Argenx Se (NASDAQ: ARGX) and Definitive Healthcare Corp (NASDAQ: DH)
Morgan Stanley Analyst forecast on MX:ARGXN
Sean Laaman
Morgan Stanley
Morgan Stanley
$21,228.18
Buy
42.54%
Upside
Assigned
09/01/26
Analysts Are Bullish on Top Healthcare Stocks: Argenx Se (ARGX), Ascendis Pharma (ASND)
Wells Fargo Analyst forecast on MX:ARGXN
Derek Archila
Wells Fargo
Wells Fargo
$22,926.43→$24,030.3
Buy
61.36%
Upside
Assigned
08/26/26
Analysts Offer Insights on Healthcare Companies: Solventum Corporation (NYSE: SOLV), Argenx Se (NASDAQ: ARGX) and Spyre Therapeutics (NASDAQ: SYRE)
UBS Analyst forecast on MX:ARGXN
Xian Deng
UBS
UBS
$16,303.24→$23,775.56
Buy
59.65%
Upside
Upgraded
08/26/26
UBS upgrades Argenx Se (ARGX) to a Buy
H.C. Wainwright Analyst forecast on MX:ARGXN
Douglas Tsao
H.C. Wainwright
H.C. Wainwright
$20,413.02
Buy
37.07%
Upside
Reiterated
08/24/26
Analysts Are Bullish on Top Healthcare Stocks: Enliven Therapeutics (ELVN), Argenx Se (ARGX)
Citizens JMP Analyst forecast on MX:ARGXN
Jason Butler
Citizens JMP
Citizens JMP
$15,827.73→$20,379.05
Buy
36.84%
Upside
Reiterated
08/18/26
Argenx price target raised to $1,200 from $932 at CitizensArgenx price target raised to $1,200 from $932 at Citizens
Truist Financial Analyst forecast on MX:ARGXN
Danielle Brill
Truist Financial
Truist Financial
$17,492.02→$18,595.88
Buy
24.87%
Upside
Reiterated
08/18/26
Argenx price target raised to $1,095 from $1,030 at TruistArgenx price target raised to $1,095 from $1,030 at Truist
Oppenheimer Analyst forecast on MX:ARGXN
Leland Gershell
Oppenheimer
Oppenheimer
$17,610.9→$18,680.8
Buy
25.44%
Upside
Reiterated
08/18/26
Argenx price target raised to $1,100 from $1,037 at OppenheimerArgenx price target raised to $1,100 from $1,037 at Oppenheimer
Citi Analyst forecast on MX:ARGXN
Samantha Semenkow
Citi
Citi
$20,430→$22,094.29
Buy
48.36%
Upside
Reiterated
08/18/26
Argenx Se (ARGX) Receives a Buy from Citi
TD Cowen Analyst forecast on MX:ARGXN
Yaron Werber
TD Cowen
TD Cowen
$19,461.99→$22,977.38
Buy
54.29%
Upside
Reiterated
08/17/26
Analysts Offer Insights on Healthcare Companies: Argenx Se (NASDAQ: ARGX) and Amgen (NASDAQ: AMGN)
Piper Sandler Analyst forecast on MX:ARGXN
Allison Bratzel
Piper Sandler
Piper Sandler
$18,256.23→$20,633.79
Buy
38.55%
Upside
Reiterated
08/17/26
Argenx price target raised to $1,215 from $1,075 at Piper SandlerArgenx price target raised to $1,215 from $1,075 at Piper Sandler
Bank of America Securities Analyst forecast on MX:ARGXN
Tazeen Ahmad
Bank of America Securities
Bank of America Securities
$18,477.01→$19,292.17
Buy
29.54%
Upside
Reiterated
08/17/26
Argenx price target raised to $1,136 from $1,088 at BofAArgenx price target raised to $1,136 from $1,088 at BofA
RBC Capital Analyst forecast on MX:ARGXN
Luca Issi
RBC Capital
RBC Capital
$17,407.11→$18,680.8
Buy
25.44%
Upside
Reiterated
08/17/26
Analysts Are Bullish on These Healthcare Stocks: Argenx Se (ARGX), Tenon Medical, Inc. (TNON)
Stocks with the Highest Top Analyst Consensus in the Healthcare Sector
ARWRArrowhead Pharmaceuticals
XENEXenon
ATECAlphatec Holdings
PTGXProtagonist Therapeutics
KNSAKiniksa Pharmaceuticals
Find stocks in the Healthcare sector that are highly recommended by Top Performing Analysts.

Best Analysts Covering Argenx Se

3 Months
Yatin SunejaGuggenheim
Success Rate
17/21 ratings generated profit
81%
Average Return
+7.85%
Copying Yatin Suneja's trades and holding each position for 3 Months would result in 80.95% of your transactions generating a profit, with an average return of +7.85% per trade.
1 Year
Tazeen AhmadBank of America Securities
Success Rate
26/27 ratings generated profit
96%
Average Return
+33.46%
Copying Tazeen Ahmad's trades and holding each position for 1 Year would result in 96.30% of your transactions generating a profit, with an average return of +33.46% per trade.
2 Years
Akash TewariJefferies
Success Rate
29/29 ratings generated profit
100%
Average Return
+72.22%
Copying Akash Tewari's trades and holding each position for 2 Years would result in 100.00% of your transactions generating a profit, with an average return of +72.22% per trade.
The Best Analyst Covering tool allows you to follow the analysts who have the best success rates and average returns on a specific stock. Only analysts that gave a Buy or Sell rating on the stock in the past 12 months are eligible for inclusion in this tool. Follow the analysts of your choice to receive real-time updates when they publish a new rating.

ARGXN Analyst Recommendation Trends

Rating
May 26
Jun 26
Jul 26
Aug 26
Sep 26
Strong Buy
5
5
4
1
0
Buy
33
51
72
67
49
Hold
3
2
2
2
2
Sell
0
0
0
0
0
Strong Sell
0
0
0
0
0
total
41
58
78
70
51
In the current month, ARGXN has received 49 Buy Ratings, 2 Hold Ratings, and 0 Sell Ratings. ARGXN average Analyst price target in the past 3 months is 20,043.65.
Each month's total comprises the sum of three months' worth of ratings.

ARGXN Financial Forecast

ARGXN Earnings Forecast

Next quarter’s earnings estimate for ARGXN is $130.42 with a range of $109.38 to $162.36. The previous quarter’s EPS was $125.50. ARGXN beat its EPS estimate ― of the time in the past 12 months, while its overall industry beat the EPS estimate 57.80% of the time in the same period. In the last calendar year ARGXN has Performed in-line its overall industry.
Next quarter’s earnings estimate for ARGXN is $130.42 with a range of $109.38 to $162.36. The previous quarter’s EPS was $125.50. ARGXN beat its EPS estimate ― of the time in the past 12 months, while its overall industry beat the EPS estimate 57.80% of the time in the same period. In the last calendar year ARGXN has Performed in-line its overall industry.

ARGXN Sales Forecast

Next quarter’s sales forecast for ARGXN is $28.24B with a range of $26.29B to $29.44B. The previous quarter’s sales results were $48.27B. ARGXN beat its sales estimates ― of the time in past 12 months, while its overall industry beat sales estimates 50.04% of the time in the same period. In the last calendar year ARGXN has Performed in-line its overall industry.
Next quarter’s sales forecast for ARGXN is $28.24B with a range of $26.29B to $29.44B. The previous quarter’s sales results were $48.27B. ARGXN beat its sales estimates ― of the time in past 12 months, while its overall industry beat sales estimates 50.04% of the time in the same period. In the last calendar year ARGXN has Performed in-line its overall industry.

ARGXN Stock Forecast FAQ

What is MX:ARGXN’s average 12-month price target, according to analysts?
Based on analyst ratings, Argenx Se’s 12-month average price target is 20,043.65.
    What is MX:ARGXN’s upside potential, based on the analysts’ average price target?
    Argenx Se has 34.59% upside potential, based on the analysts’ average price target.
      Can I see which stocks the top-ranking analysts are rating?
      Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
        How can I follow the stock ratings of top Wall Street analysts?
        Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
          Is Argenx Se a Buy, Sell or Hold?
          Argenx Se has a consensus rating of Strong Buy, which is based on 20 buy ratings, 1 hold ratings and 0 sell ratings.
            What is Argenx Se’s share price target?
            The average share price target for Argenx Se is 20,043.65. This is based on 21 Wall Streets Analysts 12-month price targets, issued in the past 3 months.
            The highest analyst share price target is $24,030.30 ,and the lowest forecast is $15,827.73. The average share price target represents 34.59% Increase from the current price of $14,892.29.
              What do analysts say about Argenx Se?
              Argenx Se’s analyst rating consensus is a Strong Buy. This is based on the ratings of 21 Wall Streets Analysts.
                How can I buy shares of Argenx Se?
                To buy shares of MX:ARGXN, you can open a brokerage account. See exclusive account opening deals on our Best Online Brokers page.